Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 836 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 476.91 USD | -2.22% | -5.56% | -9.93% | +12.58% | 11.02 B USD | ||
| 859 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.89 USD | -0.56% | -6.20% | -14.78% | +1.65% | 10.63 B USD | ||
| 865 |  IBRX ImmunityBio, Inc. - Common Stock | 9.91 USD | +1.64% | +5.20% | +25.92% | +302.85% | 10.50 B USD | ||
| 892 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.75 USD | +1.01% | +4.55% | +1.76% | +98.61% | 10.02 B USD | ||
| 909 |  KRYS Krystal Biotech, Inc. - Common Stock | 327.30 USD | +0.84% | +0.17% | -6.18% | +74.91% | 9.69 B USD | ||
| 910 |  PCVX Vaxcyte, Inc. - Common Stock | 65.02 USD | -2.90% | +14.49% | +8.38% | +53.71% | 9.68 B USD | ||
| 941 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 109.30 USD | +0.88% | -1.74% | -5.24% | +84.94% | 9.09 B USD | ||
| 943 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 139.91 USD | -0.72% | -0.77% | -4.20% | +86.22% | 9.05 B USD | ||
| 955 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 170.08 USD | -1.67% | -6.36% | -18.22% | +30.63% | 8.91 B USD | ||
| 971 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.01 USD | +1.46% | -6.68% | -16.55% | +6.73% | 8.62 B USD | ||
| 973 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 60.74 USD | -1.20% | -6.05% | -28.25% | +55.35% | 8.58 B USD | ||
| 997 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.34 USD | +0.74% | -1.53% | -1.88% | +53.01% | 8.16 B USD | ||
| 1049 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 263.55 USD | -5.20% | -9.16% | -22.39% | +380.40% | 7.36 B USD | ||
| 1058 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 43.30 USD | -1.95% | -1.97% | -23.04% | -39.96% | 7.20 B USD | ||
| 1068 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 79.90 USD | -1.18% | -12.35% | -9.28% | +234.17% | 7.05 B USD | ||
| 1075 |  ABVX Abivax SA - American Depositary Shares | 89.05 USD | +2.34% | -7.07% | -24.41% | -4.76% | 6.99 B USD | ||
| 1145 |  IMVT Immunovant, Inc. - Common Stock | 30.26 USD | -5.56% | -11.26% | -22.63% | +57.52% | 6.25 B USD | ||
| 1151 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 89.64 USD | +1.35% | -5.61% | -10.63% | -18.74% | 6.17 B USD | ||
| 1167 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 13.31 USD | +3.02% | -7.95% | +59.98% | +507.76% | 6.03 B USD | ||
| 1172 |  BLTE Belite Bio Inc - American Depositary Shares | 152.52 USD | -2.28% | -6.72% | -15.39% | +94.37% | 6.00 B USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |